Bio-Techne (NASDAQ:TECH) reported quarterly earnings results on February 04, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of $0.46,…
Bio-Techne (NASDAQ:TECH) reported quarterly earnings results on February 04, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.46, beating the consensus estimate of $0.40 by $0.06 per share. Revenue came in at $295.9M, beating the estimate of $291.1M.
Bio-Techne's stock moved following the earnings release. The stock currently trades at $65.86 with a market capitalization of $9.4B.
Current market data
NASDAQ · TECH
$72.08
Up: +$0.16 · +0.22%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
earnings ·
analyst ·
analyst ·
analyst ·
